NIFTY 50▲24,845.70
439.60 (1.80%)
SENSEX▲81,360.57
1320.77 (1.65%)
NIFTY BANK▲51,329.40
440.65 (0.87%)
INDIAN RAILWAY FINANCE CORP▲183.65
0.09 (0.05%)
TATA MOTORS▲1,116.65
25.70 (2.36%)
TATA STEEL▲162.60
5.21 (3.31%)
TATA POWER▲444.60
21.25 (5.02%)
SUZLON ENERGY▲62.11
0.64 (1.04%)
RAIL VIKAS NIGAM▼555.45
-20.25 (-3.52%)
INDIAN RENEWABLE ENERGY▼258.55
-2.63 (-1.01%)
VODAFONE IDEA▲15.98
0.80 (5.27%)
RELIANCE INDUSTRIES▲3,014.95
30.15 (1.01%)
YES BANK▲24.95
0.33 (1.34%)
ADANI POWER▲713.00
17.80 (2.56%)
NHPC▲104.54
2.58 (2.53%)
STATE BANK OF INDIA▲860.15
11.65 (1.37%)
HDFC BANK▲1,618.25
1.65 (0.10%)
RELIANCE POWER▲29.71
0.02 (0.07%)
JIO FIN SERVICES LTD▲331.95
2.75 (0.84%)
ZOMATO▲225.50
6.19 (2.82%)
ADANI PORT & SEZ▲1,539.40
52.40 (3.52%)
BHARAT ELECTRONICS▲310.30
8.85 (2.94%)
INDIAN RAILWAY TOURISM CORP▲982.85
13.70 (1.41%)
INDIAN OIL CORP▼176.40
-0.45 (-0.25%)
RATTANINDIA POWER▲16.90
0.09 (0.54%)
MRF▲1,38,400.00
809.90 (0.59%)
ADANI ENTERPRISES▲3,073.10
99.60 (3.35%)
JAIPRAKASH POWER VENTURES▲19.67
0.84 (4.46%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/NSE_EQ|INE023H01027.png)
Nectar Lifesciences Share Price
NECLIFE
₹32.15+₹1.82 (6.00%) TodayLast updated on 26 Jul, 2024 | 15:29 IST
₹30.50₹33.09
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹30.50 | Close₹30.33 |
Circuit range₹36.39 - ₹24.26 | Day range₹30.50 - ₹33.09 | Year range₹21.50 - ₹45.70 |
Volume22,13,372 | Avg. traded₹32.19 | Revenue (12m)₹1,686 Crs |
Nectar LifesciencesNectar Lifesciences Limited is an India-based pharmaceutical company. The Company's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The Company offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.
Nectar Lifesciences Key indicators
52 week high₹45.70 | 52 week low₹21.50 | P/E ratio124.09 |
P/B ratio0.64 | ROE-2.09% | ROCE2.06% |
Dividend yield-- | Debt/Equity ratio0.71 | EPS-1 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin5.61% | Net profit margin-1.29% |
ROE-2.09% | ROA-0.99% |
ROCE2.06% |
Learn more
Nectar Lifesciences Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Jul 25 2024 | ₹29.19 | ₹30.33 | |
Wed, Jul 24 2024 | ₹28.54 | ₹29.41 | |
Tue, Jul 23 2024 | ₹28.85 | ₹28.54 | |
Mon, Jul 22 2024 | ₹27.90 | ₹28.46 | |
Fri, Jul 19 2024 | ₹28.77 | ₹28.06 | -1.85% |
Thu, Jul 18 2024 | ₹28.80 | ₹28.59 | -1.75% |
Tue, Jul 16 2024 | ₹29.48 | ₹29.10 | -0.72% |
Mon, Jul 15 2024 | ₹29.85 | ₹29.31 | -1.31% |